{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:11:00Z","timestamp":1780103460899,"version":"3.54.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Oxidized LDL (oxLDL) is involved in the development of atherosclerotic heart disease through a mechanism that is not fully understood. In this study, we examined the role of malondialdehyde (MDA), an important oxidative stress epitope of oxLDL, in mediating coronary endothelial cytotoxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Human coronary artery endothelial cells (HCAECs) were treated with oxLDL in the presence or absence of antibody against MDA (anti-MDA) or apoB100 (anti-apoB100). In HCAECs treated with oxLDL (100 \u03bcg\/ml) alone, DNA synthesis, cell viability, and expression of prosurvival fibroblast growth factor 2 (FGF2) were significantly reduced (<jats:italic>P<\/jats:italic>&lt; 0.01 vs phosphate buffered saline\u2013treated cells). These inhibitory effects of oxLDL were significantly attenuated in HCAECs cotreated with anti-MDA (0.15 \u03bcg\/ml;<jats:italic>P<\/jats:italic>&lt; 0.05 vs oxLDL-treated cells), but not in those cotreated with anti-apoB100. When we tested the effects of a panel of signal transduction modifiers on the signal transduction pathways of MDA in oxLDL-treated HCAECs, we found that MDA-induced cytotoxicity was mediated partly through the Akt pathway. Using a reporter gene assay, we identified an oxLDL-response element in the<jats:italic>FGF2<\/jats:italic>promoter that was responsible for the transcriptional repression of<jats:italic>FGF2<\/jats:italic>by oxLDL. The results of bisulfite genomic DNA sequencing showed that in HCAECs treated with oxLDL, the GC-rich promoter of<jats:italic>FGF2<\/jats:italic>was heavily methylated at cytosine residues, whereas cotreatment with anti-MDA markedly reduced oxLDL-induced<jats:italic>FGF2<\/jats:italic>promoter methylation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>OxLDL disrupts the growth and survival of HCAECs through an MDA-dependent pathway involving methylation of the<jats:italic>FGF2<\/jats:italic>promoter and repression of<jats:italic>FGF2<\/jats:italic>transcription. This novel epigenetic mechanism of oxLDL may underlie its atherogenicity in patients with atherosclerotic cardiovascular disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1423-0127-21-11","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T14:03:05Z","timestamp":1391436185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation"],"prefix":"10.1186","volume":"21","author":[{"given":"Tzu-Ching","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwu-Fen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Huang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Chun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,3]]},"reference":[{"key":"558_CR1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1161\/01.CIR.103.15.1955","volume":"103","author":"S Ehara","year":"2001","unstructured":"Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T: Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001, 103: 1955-1960. 10.1161\/01.CIR.103.15.1955.","journal-title":"Circulation"},{"key":"558_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrcardio.2011.62","volume":"8","author":"C Lahoute","year":"2011","unstructured":"Lahoute C, Herbin O, Mallat Z, Tedgui A: Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol. 2011, 8: 348-358. 10.1038\/nrcardio.2011.62.","journal-title":"Nat Rev Cardiol"},{"key":"558_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","volume":"45","author":"M Navab","year":"2004","unstructured":"Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N: The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004, 45: 993-1007. 10.1194\/jlr.R400001-JLR200.","journal-title":"J Lipid Res"},{"key":"558_CR4","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/hq0801.093587","volume":"21","author":"PX Shaw","year":"2001","unstructured":"Shaw PX, Horkko S, Tsimikas S, Chang MK, Palinski W, Silverman GJ, Chen PP, Witztum JL: Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol. 2001, 21: 1333-1339. 10.1161\/hq0801.093587.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"558_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/MCO.0b013e3282f0c97c","volume":"10","author":"T Grune","year":"2007","unstructured":"Grune T, Berger MM: Markers of oxidative stress in ICU clinical settings: present and future. Curr Opin Clin Nutr Metab Care. 2007, 10: 712-717. 10.1097\/MCO.0b013e3282f0c97c.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"558_CR6","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2010.08.001","volume":"49","author":"MJ Duryee","year":"2010","unstructured":"Duryee MJ, Klassen LW, Schaffert CS, Tuma DJ, Hunter CD, Garvin RP, Anderson DR, Thiele GM: Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic Biol Med. 2010, 49: 1480-1486. 10.1016\/j.freeradbiomed.2010.08.001.","journal-title":"Free Radic Biol Med"},{"key":"558_CR7","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2011.07.017","volume":"58","author":"S Tsimikas","year":"2011","unstructured":"Tsimikas S, Miyanohara A, Hartvigsen K, Merki E, Shaw PX, Chou MY, Pattison J, Torzewski M, Sollors J, Friedmann T: Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol. 2011, 58: 1715-1727. 10.1016\/j.jacc.2011.07.017.","journal-title":"J Am Coll Cardiol"},{"key":"558_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.atherosclerosis.2012.08.006","volume":"224","author":"MF Lopes-Virella","year":"2012","unstructured":"Lopes-Virella MF, Hunt KJ, Baker NL, Virella G, Moritz T: The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study. Atherosclerosis. 2012, 224: 526-531. 10.1016\/j.atherosclerosis.2012.08.006.","journal-title":"Atherosclerosis"},{"key":"558_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1074\/jbc.270.1.319","volume":"270","author":"JK Liao","year":"1995","unstructured":"Liao JK, Shin WS, Lee WY, Clark SL: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995, 270: 319-324. 10.1074\/jbc.270.1.319.","journal-title":"J Biol Chem"},{"key":"558_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1172\/JCI117816","volume":"95","author":"JK Liao","year":"1995","unstructured":"Liao JK, Clark SL: Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest. 1995, 95: 1457-1463. 10.1172\/JCI117816.","journal-title":"J Clin Invest"},{"key":"558_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/hc3101.092213","volume":"104","author":"PY Chang","year":"2001","unstructured":"Chang PY, Luo S, Jiang T, Lee YT, Lu SC, Henry PD, Chen CH: Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. Circulation. 2001, 104: 588-593. 10.1161\/hc3101.092213.","journal-title":"Circulation"},{"key":"558_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/01.CIR.101.2.171","volume":"101","author":"CH Chen","year":"2000","unstructured":"Chen CH, Jiang W, Via DP, Luo S, Li TR, Lee YT, Henry PD: Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation. 2000, 101: 171-177. 10.1161\/01.CIR.101.2.171.","journal-title":"Circulation"},{"key":"558_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.ATV.17.7.1303","volume":"17","author":"CH Chen","year":"1997","unstructured":"Chen CH, Cartwright J, Li Z, Lou S, Nguyen HH, Gotto AM, Henry PD: Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants. Essential role of basic fibroblast growth factor. Arterioscler Thromb Vasc Biol. 1997, 17: 1303-1312. 10.1161\/01.ATV.17.7.1303.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"558_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","volume":"141","author":"G Seghezzi","year":"1998","unstructured":"Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P: Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998, 141: 1659-1673. 10.1083\/jcb.141.7.1659.","journal-title":"J Cell Biol"},{"key":"558_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0008-6363(97)00029-1","volume":"34","author":"CP Tiefenbacher","year":"1997","unstructured":"Tiefenbacher CP, Chilian WM: Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation. Cardiovasc Res. 1997, 34: 411-417. 10.1016\/S0008-6363(97)00029-1.","journal-title":"Cardiovasc Res"},{"key":"558_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.108.171082","volume":"102","author":"PY Chang","year":"2008","unstructured":"Chang PY, Lu SC, Lee CM, Chen YJ, Dugan TA, Huang WH, Chang SF, Liao WS, Chen CH, Lee YT: Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res. 2008, 102: 933-941. 10.1161\/CIRCRESAHA.108.171082.","journal-title":"Circ Res"},{"key":"558_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/01.ATV.0000071350.78872.C4","volume":"23","author":"CY Yang","year":"2003","unstructured":"Yang CY, Raya JL, Chen HH, Chen CH, Abe Y, Pownall HJ, Taylor AA, Smith CV: Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. Arterioscler Thromb Vasc Biol. 2003, 23: 1083-1090. 10.1161\/01.ATV.0000071350.78872.C4.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"558_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/08977199109043913","volume":"4","author":"F Shibata","year":"1991","unstructured":"Shibata F, Baird A, Florkiewicz RZ: Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors. 1991, 4: 277-287. 10.3109\/08977199109043913.","journal-title":"Growth Factors"},{"key":"558_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/321209a0","volume":"321","author":"AP Bird","year":"1986","unstructured":"Bird AP: CpG-rich islands and the function of DNA methylation. Nature. 1986, 321: 209-213. 10.1038\/321209a0.","journal-title":"Nature"},{"key":"558_CR20","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1073\/pnas.052410099","volume":"99","author":"D Takai","year":"2002","unstructured":"Takai D, Jones PA: Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A. 2002, 99: 3740-3745. 10.1073\/pnas.052410099.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"558_CR21","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1194\/jlr.M400229-JLR200","volume":"45","author":"PY Chang","year":"2004","unstructured":"Chang PY, Lu SC, Su TC, Chou SF, Huang WH, Morrisett JD, Chen CH, Liau CS, Lee YT: Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res. 2004, 45: 2116-2122. 10.1194\/jlr.M400229-JLR200.","journal-title":"J Lipid Res"},{"key":"558_CR22","first-page":"159","volume":"79","author":"S Klein","year":"1997","unstructured":"Klein S, Roghani M, Rifkin DB: Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. EXS. 1997, 79: 159-192.","journal-title":"EXS"},{"key":"558_CR23","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1001\/jama.281.18.1718","volume":"281","author":"P Holvoet","year":"1999","unstructured":"Holvoet P, Collen D, Van de Werf F: Malondialdehyde-modified LDL as a marker of acute coronary syndromes. JAMA. 1999, 281: 1718-1721. 10.1001\/jama.281.18.1718.","journal-title":"JAMA"},{"key":"558_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1083\/jcb.127.1.203","volume":"127","author":"MK Stachowiak","year":"1994","unstructured":"Stachowiak MK, Moffett J, Joy A, Puchacz E, Florkiewicz R, Stachowiak EK: Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J Cell Biol. 1994, 127: 203-223. 10.1083\/jcb.127.1.203.","journal-title":"J Cell Biol"},{"key":"558_CR25","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1073\/pnas.93.6.2470","volume":"93","author":"J Moffett","year":"1996","unstructured":"Moffett J, Kratz E, Florkiewicz R, Stachowiak MK: Promoter regions involved in density-dependent regulation of basic fibroblast growth factor gene expression in human astrocytic cells. Proc Natl Acad Sci U S A. 1996, 93: 2470-2475. 10.1073\/pnas.93.6.2470.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"558_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1194\/jlr.M700305-JLR200","volume":"49","author":"D Tang","year":"2008","unstructured":"Tang D, Lu J, Walterscheid JP, Chen HH, Engler DA, Sawamura T, Chang PY, Safi HJ, Yang CY, Chen CH: Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. J Lipid Res. 2008, 49: 33-47. 10.1194\/jlr.M700305-JLR200.","journal-title":"J Lipid Res"},{"key":"558_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cvr\/cvt062","volume":"99","author":"PY Chang","year":"2013","unstructured":"Chang PY, Chen YJ, Chang FH, Lu J, Huang WH, Yang TC, Lee YT, Chang SF, Lu SC, Chen CH: Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction. Cardiovasc Res. 2013, 99: 137-145.","journal-title":"Cardiovasc Res"},{"key":"558_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00395-012-0245-9","volume":"107","author":"JM Lorenzen","year":"2012","unstructured":"Lorenzen JM, Martino F, Thum T: Epigenetic modifications in cardiovascular disease. Basic Res Cardiol. 2012, 107: 245-","journal-title":"Basic Res Cardiol"},{"key":"558_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2217\/epi.10.70","volume":"3","author":"M Movassagh","year":"2011","unstructured":"Movassagh M, Vujic A, Foo R: Genome-wide DNA methylation in human heart failure. Epigenomics. 2011, 3: 103-109. 10.2217\/epi.10.70.","journal-title":"Epigenomics"},{"key":"558_CR30","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","volume":"123","author":"DE Handy","year":"2011","unstructured":"Handy DE, Castro R, Loscalzo J: Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011, 123: 2145-2156. 10.1161\/CIRCULATIONAHA.110.956839.","journal-title":"Circulation"},{"key":"558_CR31","doi-asserted-by":"publisher","first-page":"H506","DOI":"10.1152\/ajpheart.00252.2011","volume":"301","author":"S Mitra","year":"2011","unstructured":"Mitra S, Khaidakov M, Lu J, Ayyadevara S, Szwedo J, Wang XW, Chen C, Khaidakov S, Kasula SR, Stone A: Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. Am J Physiol Heart Circ Physiol. 2011, 301: H506-H513. 10.1152\/ajpheart.00252.2011.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"558_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1745-7270.2007.00251.x","volume":"39","author":"Y Huang","year":"2007","unstructured":"Huang Y, Peng K, Su J, Huang Y, Xu Y, Wang S: Different effects of homocysteine and oxidized low density lipoprotein on methylation status in the promoter region of the estrogen receptor alpha gene. Acta Biochim Biophys Sin (Shanghai). 2007, 39: 19-26.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"558_CR33","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1096\/fj.10-174904","volume":"25","author":"KC Chen","year":"2011","unstructured":"Chen KC, Wang YS, Hu CY, Chang WC, Liao YC, Dai CY, Juo SH: OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2\/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 2011, 25: 1718-1728. 10.1096\/fj.10-174904.","journal-title":"FASEB J"},{"key":"558_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-134-7-200104030-00011","volume":"134","author":"V Santini","year":"2001","unstructured":"Santini V, Kantarjian HM, Issa JP: Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med. 2001, 134: 573-586. 10.7326\/0003-4819-134-7-200104030-00011.","journal-title":"Ann Intern Med"},{"key":"558_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1194\/jlr.M400339-JLR200","volume":"46","author":"E Nakano","year":"2005","unstructured":"Nakano E, Taiwo FA, Nugent D, Griffiths HR, Aldred S, Paisi M, Kwok M, Bhatt P, Hill MH, Moat S, Powers HJ: Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system. J Lipid Res. 2005, 46: 484-493.","journal-title":"J Lipid Res"},{"key":"558_CR36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1006\/bbrc.2001.4374","volume":"281","author":"M Nagase","year":"2001","unstructured":"Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T: Redox-sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem Biophys Res Commun. 2001, 281: 720-725. 10.1006\/bbrc.2001.4374.","journal-title":"Biochem Biophys Res Commun"},{"key":"558_CR37","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/01.ATV.0000033829.14012.18","volume":"22","author":"K Nishi","year":"2002","unstructured":"Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, Nagahiro S: Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol. 2002, 22: 1649-1654. 10.1161\/01.ATV.0000033829.14012.18.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"558_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa043175","volume":"353","author":"S Tsimikas","year":"2005","unstructured":"Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB: Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005, 353: 46-57. 10.1056\/NEJMoa043175.","journal-title":"N Engl J Med"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1423-0127-21-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T06:24:44Z","timestamp":1688970284000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/1423-0127-21-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1186\/1423-0127-21-11","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,3]]},"assertion":[{"value":"1 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}